Biacore systems in discovery and early-stage development of biotherapeutic antibodies

Advances in antibody use for the treatment of disease has driven demand for new antibody formats designed to improve the efficacy of therapy and reach new targets. Biacore™ systems are extensively used in biotherapeutic antibody discovery and development. In this whitepaper from Cytiva, explore the utility of Biacore systems at all stages of the process from selection of first candidates to clinical lead. Furthermore, learn how a combination of Biacore instruments, software, sensor chips, and kits support the setup of screening and characterization assays and reduces assay development efforts.